Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

The US Supreme Court will hear generic drug maker Hikma Pharmaceuticals USA Inc.'s challenge of an appeals court holding that ...

This flu season has been rough. Antivirals can help.

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...

India's first private drug quality audit finds generics match branded medicines for safety and efficacy—at a fraction of the price—reviving questions over doctors' reluctance to prescribe them.

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

Generic medicines, which are clinically equivalent to their branded counterparts, are a cornerstone in efforts to improve healthcare affordability and broaden patient access to essential treatments.

Study breaks down high U.S. drug pricing. — -- High prescription drug prices in the United States are largely due to drug monopolies and restrictions on price negotiations, according to a new ...

Ever since President Donald Trump started promising to slap tariffs on pharmaceutical imports, drugmakers have unveiled a flurry of commitments to build or expand US manufacturing operations in the ...